Matt Larew
Stock Analyst at William Blair
(4.70)
# 821
Out of 5,184 analysts
232
Total ratings
56%
Success rate
17.1%
Average return
Main Sectors:
Stocks Rated by Matt Larew
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STVN Stevanato Group | Downgraded: Hold | n/a | $15.65 | - | 14 | Nov 4, 2026 | |
| NEO NeoGenomics | Reiterated: Hold | n/a | $14.82 | - | 3 | Oct 6, 2026 | |
| OPCH Option Care Health | Reiterated: Buy | n/a | $31.59 | - | 14 | Oct 6, 2026 | |
| RVTY Revvity | Initiated Coverage: Buy | n/a | $145.22 | - | 1 | Oct 5, 2026 | |
| TKNO Alpha Teknova | Reiterated: Buy | n/a | $7.63 | - | 10 | Sep 30, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | n/a | $51.80 | - | 11 | Sep 29, 2026 | |
| AVTR Avantor | Reiterated: Hold | n/a | $14.84 | - | 10 | Sep 21, 2026 | |
| VCYT Veracyte | Reiterated: Buy | n/a | $25.13 | - | 2 | Sep 15, 2026 | |
| GH Guardant Health | Reiterated: Buy | n/a | $145.83 | - | 5 | Sep 8, 2026 | |
| QGEN Qiagen | Rated: Hold | n/a | $49.30 | - | 3 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.81 | - | 2 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.1074 | - | 1 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $72.67 | - | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.67 | - | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.98 | - | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $273.40 | - | 1 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.56 | - | 1 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $89.92 | - | 1 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $440.45 | - | 6 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $70.00 | - | 2 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $103.32 | - | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $140.08 | - | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $54.04 | - | 2 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.93 | - | 1 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $163.81 | - | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $669.54 | - | 11 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $390.30 | - | 12 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $220.36 | - | 9 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.37 | - | 10 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $7.46 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $314.32 | n/a | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $95.93 | n/a | 4 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.54 | n/a | 1 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.16 | n/a | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | - | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $161.03 | n/a | 4 | Sep 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $367.13 | n/a | 1 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $133.65 | n/a | 1 | Nov 21, 2017 |
Stevanato Group
Nov 4, 2026
Downgraded: Hold
Price Target: n/a
Current: $15.65
Upside: -
NeoGenomics
Oct 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.82
Upside: -
Option Care Health
Oct 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.59
Upside: -
Revvity
Oct 5, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $145.22
Upside: -
Alpha Teknova
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.63
Upside: -
10x Genomics
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $51.80
Upside: -
Avantor
Sep 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.84
Upside: -
Veracyte
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.13
Upside: -
Guardant Health
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $145.83
Upside: -
Qiagen
Aug 24, 2026
Rated: Hold
Price Target: n/a
Current: $49.30
Upside: -
Aug 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.81
Upside: -
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.1074
Upside: -
Aug 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $72.67
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.67
Upside: -
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.98
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $273.40
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.56
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $89.92
Upside: -
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $440.45
Upside: -
Aug 3, 2026
Rated: Hold
Price Target: n/a
Current: $70.00
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $103.32
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $140.08
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $54.04
Upside: -
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.93
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $163.81
Upside: -
Jul 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $669.54
Upside: -
Jul 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $390.30
Upside: -
Jul 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $220.36
Upside: -
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $1.37
Upside: -
May 11, 2026
Reiterated: Sell
Price Target: n/a
Current: $7.46
Upside: -
Oct 11, 2025
Upgraded: Buy
Price Target: n/a
Current: $314.32
Upside: n/a
Oct 8, 2024
Reiterated: Hold
Price Target: n/a
Current: $95.93
Upside: n/a
Aug 22, 2022
Reiterated: Buy
Price Target: n/a
Current: $14.54
Upside: n/a
Sep 22, 2021
Downgraded: Hold
Price Target: n/a
Current: $9.16
Upside: n/a
Aug 4, 2021
Downgraded: Hold
Price Target: n/a
Current: -
Upside: n/a
Sep 11, 2019
Downgraded: Hold
Price Target: n/a
Current: $161.03
Upside: n/a
Dec 3, 2018
Reiterated: Buy
Price Target: n/a
Current: $367.13
Upside: n/a
Nov 21, 2017
Initiated Coverage: Buy
Price Target: n/a
Current: $133.65
Upside: n/a